Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancer

Research output: Contribution to journalComment/debate

11 Scopus citations
Original languageEnglish
Pages (from-to)7965-7966
Number of pages2
JournalClinical Cancer Research
Volume11
Issue number22
DOIs
StatePublished - 15 Nov 2005
Externally publishedYes

Cite this